tiprankstipranks
Trending News
More News >
Biofrontera AG (GB:0DOL)
:0DOL

Biofrontera (0DOL) Price & Analysis

Compare
0 Followers

0DOL Stock Chart & Stats


Financials

0DOL FAQ

What was Biofrontera AG’s price range in the past 12 months?
Biofrontera AG lowest share price was €14.30 and its highest was €14.30 in the past 12 months.
    What is Biofrontera AG’s market cap?
    Biofrontera AG’s market cap is €15.07M.
      When is Biofrontera AG’s upcoming earnings report date?
      Biofrontera AG’s upcoming earnings report date is Jun 03, 2026 which is in 329 days.
        How were Biofrontera AG’s earnings last quarter?
        Currently, no data Available
        Is Biofrontera AG overvalued?
        According to Wall Street analysts Biofrontera AG’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Biofrontera AG pay dividends?
          Biofrontera AG pays a Notavailable dividend of €0.285 which represents an annual dividend yield of N/A. See more information on Biofrontera AG dividends here
            What is Biofrontera AG’s EPS estimate?
            Biofrontera AG’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Biofrontera AG have?
            Biofrontera AG has 6,076,862 shares outstanding.
              What happened to Biofrontera AG’s price movement after its last earnings report?
              Currently, no data Available
              Which hedge fund is a major shareholder of Biofrontera AG?
              Currently, no hedge funds are holding shares in GB:0DOL

              Biofrontera Stock Smart Score

              5
              Neutral
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              0.00%
              12-Months-Change

              Fundamentals

              Return on Equity
              -22.41%
              Trailing 12-Months
              Asset Growth
              -3.56%
              Trailing 12-Months

              Company Description

              Biofrontera AG

              Biofrontera AG, a biopharmaceutical company, engages in the research, development, and marketing of dermatological products. Its products include Ameluz and BF-RhodoLED lamp for the treatment of mild and moderate actinic keratoses on the face and scalp, field cancerization, and fatal squamous cell carcinoma. The company also develops RhodoLED XL for the treatment of multiple interspersed lesions; Belixos, a modern active cosmetic product for irritated and sensitive skin; and Xepi for the treatment of antibiotic-resistant bacteria. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany.
              Similar Stocks
              Company
              Price & Change
              Follow
              aap Implantate
              Geratherm Medical
              PAION AG
              SynBiotic SE
              Bio-Gate AG
              Popular Stocks
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis